Clinical Genomics: A Guide to Clinical Next Generation Sequencing
Editat de Shashikant Kulkarni, Somak Royen Limba Engleză Paperback – 13 iul 2026
Structured for ease of reference, this book covers targeted gene sequencing methods, whole exome/genome approaches, emerging technologies such as long-read sequencing, and critical considerations for assay validation. Detailed sections address bioinformatics workflows, variant detection and interpretation methodologies, integration with clinical informatics systems, and essential IT infrastructure, including cloud-based solutions.
This book also thoroughly addresses practical topics essential to laboratory management, such as regulatory compliance, ethical frameworks, billing strategies, and reimbursement paradigms, helping directors navigate the evolving landscape of genomic diagnostics.
- Technical guidance: In-depth overview of sequencing platforms, chemistries, targeted capture methods, RNA sequencing, and methylome analysis for informed assay design and validation
- Bioinformatics workflows: Practical approaches for implementing pipelines to accurately detect and interpret genomic variants, structural changes, and complex genomic alterations
- Clinical implementation: Real-world applications for both constitutional and somatic disorders, including cancer diagnostics and precision medicine strategies
- Regulatory and ethical insights: Current regulatory requirements, ethical considerations, legal implications, and genomic reference standards pertinent to clinical practice
- Operational and financial considerations: Guidance on billing, reimbursement, and operational integration of genomic medicine into clinical practice and electronic health records
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 1000.90 lei Precomandă | |
| ELSEVIER SCIENCE – 13 iul 2026 | 1000.90 lei Precomandă | |
| Hardback (1) | 728.76 lei 5-7 săpt. | |
| ELSEVIER SCIENCE – 12 noi 2014 | 728.76 lei 5-7 săpt. |
Preț: 1000.90 lei
Preț vechi: 1446.86 lei
-31% Precomandă
Puncte Express: 1501
Preț estimativ în valută:
177.12€ • 207.69$ • 155.54£
177.12€ • 207.69$ • 155.54£
Carte nepublicată încă
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323900249
ISBN-10: 0323900240
Pagini: 562
Ilustrații: 120 illustrations (120 in full color)
Dimensiuni: 216 x 276 mm
Ediția:2
Editura: ELSEVIER SCIENCE
ISBN-10: 0323900240
Pagini: 562
Ilustrații: 120 illustrations (120 in full color)
Dimensiuni: 216 x 276 mm
Ediția:2
Editura: ELSEVIER SCIENCE
Cuprins
Section I: Methods
1. Overview of Technical Aspects and Chemistries of Next-Generation Sequencing
2. Targeted Hybrid Capture Methods
3. Amplification-Based Methods
4. Emerging DNA Sequencing Technologies
5. Transcriptomics, RNA-Sequencing and Methylome Analysis
Section II: Bioinformatics
6. Base Calling, Read Mapping, and Coverage Analysis
7. Single Nucleotide Variant Detection Using Next Generation Sequencing
8. Insertions and Deletions (Indels)
9. Translocation Detection Using Next-Generation Sequencing
10. Copy Number Variant Detection Using Next-Generation Sequencing
11. Reference Databases for Disease Associations
12. Reporting of Clinical Genomics Test Results
13. Reporting Software
14. Constitutional Diseases: Target enrichment strategies for Targeted gene sequencing panels
15. Targeted Hybrid Capture for Inherited Disease Panels
16. Constitutional Disorders: Whole Exome and Whole Genome Sequencing
17. Somatic Diseases (Cancer): Amplification-Based Next-Generation Sequencing
18. Targeted Hybrid-Capture for Somatic Mutation Detection in the Clinic
19. Somatic Diseases (Cancer): Whole Exome and Whole Genome Sequencing
20. Assay Validation
21. Regulatory Considerations Related to Clinical Next Generation Sequencing
22. Genomic Reference Materials for Clinical Applications
23. Ethical Challenges in Clinical Genomics
24. Legal Issues
25. Billing and Reimbursement
Section III: Clinical Informatics and IT Infrastructure
26. Cloud Computing for Clinical NGS Testing
Section III: Interpretation
27. Bioinformatics of Long Read Sequencing
Section IV: Regulation, Reimbursement, and Legal Issues
28. Business aspect of Precision Genomic Medicine
29. Driving precision medicine through genomics-EHR integration
1. Overview of Technical Aspects and Chemistries of Next-Generation Sequencing
2. Targeted Hybrid Capture Methods
3. Amplification-Based Methods
4. Emerging DNA Sequencing Technologies
5. Transcriptomics, RNA-Sequencing and Methylome Analysis
Section II: Bioinformatics
6. Base Calling, Read Mapping, and Coverage Analysis
7. Single Nucleotide Variant Detection Using Next Generation Sequencing
8. Insertions and Deletions (Indels)
9. Translocation Detection Using Next-Generation Sequencing
10. Copy Number Variant Detection Using Next-Generation Sequencing
11. Reference Databases for Disease Associations
12. Reporting of Clinical Genomics Test Results
13. Reporting Software
14. Constitutional Diseases: Target enrichment strategies for Targeted gene sequencing panels
15. Targeted Hybrid Capture for Inherited Disease Panels
16. Constitutional Disorders: Whole Exome and Whole Genome Sequencing
17. Somatic Diseases (Cancer): Amplification-Based Next-Generation Sequencing
18. Targeted Hybrid-Capture for Somatic Mutation Detection in the Clinic
19. Somatic Diseases (Cancer): Whole Exome and Whole Genome Sequencing
20. Assay Validation
21. Regulatory Considerations Related to Clinical Next Generation Sequencing
22. Genomic Reference Materials for Clinical Applications
23. Ethical Challenges in Clinical Genomics
24. Legal Issues
25. Billing and Reimbursement
Section III: Clinical Informatics and IT Infrastructure
26. Cloud Computing for Clinical NGS Testing
Section III: Interpretation
27. Bioinformatics of Long Read Sequencing
Section IV: Regulation, Reimbursement, and Legal Issues
28. Business aspect of Precision Genomic Medicine
29. Driving precision medicine through genomics-EHR integration
Recenzii
"...presents key bioinformatic challenges and the solutions that must be addressed by clinical genomicists and genomic pathologists, such as specific pipelines for identification of the full range of variants that are clinically important." --Anticancer Research, February 2015